TY - JOUR
KW - Buprenorphine/therapeutic use
KW - COVID-19/diagnosis/epidemiology
KW - Female
KW - Humans
KW - Male
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Pandemics/legislation & jurisprudence
KW - Retrospective Studies
KW - SARS-CoV-2
KW - Telemedicine/organization & administration/statistics & numerical data
KW - COVID-19
KW - Controlled Substances
KW - Disasters
KW - Opioids
KW - Pandemics
KW - Primary Health Care
KW - Substance Abuse
KW - Telemedicine
KW - Vulnerable Populations
AU - D. T. O'Gurek
A1 - 
AD - From the Department of Family & Community Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
BT - Journal of the American Board of Family Medicine : JABFM
C5 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - Suppl
CY - United States
DO - 10.3122/jabfm.2021.S1.200207
IS - Suppl
JF - Journal of the American Board of Family Medicine : JABFM
LA - eng
M1 - Journal Article
PB - by the American Board of Family Medicine
PP - United States
PY - 2021
SN - 1558-7118; 1557-2625
SP - S136
EP - S140
EP - 
T1 - Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting
T2 - Journal of the American Board of Family Medicine : JABFM
TI - Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting
U1 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 33622828
U3 - 10.3122/jabfm.2021.S1.200207
VL - 34
VO - 1558-7118; 1557-2625
Y1 - 2021
Y2 - Feb
ER -